Mechanisms of carcinogenesis : from initiation and promotion to the hallmarks

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor Promotion

  2020cited by this paper
• Radiation

  2019cited by this paper
• International Agency for Research on Cancer (IARC)

  2018cited by this paper
• The association between health-related quality of life and survival in patients with head and neck cancer: a systematic review

  2015cited by this paper
• The mutational landscapes of genetic and chemical models of Kras-driven lung cancer

  2014cited by this paper
• Chronic Arsenic Exposure and Angiogenesis in Human Bronchial Epithelial Cells via the ROS/miR-199a-5p/HIF-1α/COX-2 Pathway

  2014cited by this paper
• Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers

  2014cited by this paper
• In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.

  2013cited by this paper
• Nongenotoxic carcinogenicity of chemicals: mechanisms of action and early recognition through a new set of structural alerts.

  2013cited by this paper
• Genomic landscape of non-small-cell lung cancer in smokers and never-smokers

  2013influential reference
• Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.

  2012cited by this paper
• Deconstructing p53 transcriptional networks in tumor suppression.

  2012cited by this paper
• Cancer genetics and epigenetics: two sides of the same coin?

  2012cited by this paper
• Cancer cell metabolism: one hallmark, many faces.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.

  2012cited by this paper
• Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

  2012cited by this paper
• Toxicology: The learning curve

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

  2012cited by this paper
• Factors influencing mutagenic mode of action determinations of regulatory and advisory agencies.

  2012influential reference
• Nicotine: specific role in angiogenesis, proliferation and apoptosis

  2012cited by this paper
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

  2012cited by this paper
• Insights into Pancreatic Cancer Etiology from Pathway Analysis of Genome-Wide Association Study Data

  2012cited by this paper
• The rainbow trout liver cancer model: response to environmental chemicals and studies on promotion and chemoprevention.

  2012cited by this paper
• Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification

  2011cited by this paper
• TP53 mutations in human cancer: database reassessment and prospects for the next decade.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011influential reference
• Epigenetic setting for long-term expression of estrogen receptor α and androgen receptor in cells.

  2011cited by this paper
• Genetic basis for susceptibility to lung cancer: Recent progress and future directions.

  2010cited by this paper
• Quantitative Cancer Risk Assessment of Nongenotoxic Carcinogens

  2010cited by this paper
• Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

  2010cited by this paper
• Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.

  2009cited by this paper
• The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

  2009cited by this paper
• [Biological agents].

  2009cited by this paper
• A review of human carcinogens--Part F: chemical agents and related occupations.

  2009cited by this paper
• Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?

  2009cited by this paper
• Biological functions of the arylhydrocarbon receptor: beyond induction of cytochrome P450s. Introduction to this special issue.

  2009cited by this paper
• A small cell lung cancer genome reports complex tobacco exposure signatures

  2009cited by this paper
• Advances in chemical carcinogenesis: a historical review and prospective.

  2008cited by this paper
• Molecular-targeted therapies: lessons from years of clinical development.

  2008cited by this paper
• Epigenetic remodeling during arsenical-induced malignant transformation.

  2008cited by this paper
• Epigenetic aspects of genotoxic and non‐genotoxic hepatocarcinogenesis: Studies in rodents

  2008cited by this paper
• Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies

  2007cited by this paper
• Molecular Carcinogenesis and the Molecular Biology of Human Cancer

  2007cited by this paper
• Nickel carcinogenesis: epigenetics and hypoxia signaling.

  2005cited by this paper
• Genes that Regulate Metastasis and Angiogenesis

  2000cited by this paper
• Molecular Mechanisms of Tumor Angiogenesis and Tumor Progression

  2000cited by this paper
• Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes.

  1998cited by this paper
• Can ends justify the means?: telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells.

  1998cited by this paper
• Cancer-susceptibility genes. Gatekeepers and caretakers.

  1997cited by this paper
• Activation of mitogen activated protein kinase in dolichyl phosphate-induced apoptosis in U937 cells.

  1996cited by this paper
• Microsatellite Instability: Marker of a Mutator Phenotype in Cancer

  1994cited by this paper
• Use of short-term tests in determining the genotoxicity or nongenotoxicity of chemicals.

  1992cited by this paper
• Tumour suppressor genes, multistage carcinogenesis and molecular epidemiology.

  1992cited by this paper
• Chemically induced cell proliferation in carcinogenesis.

  1992cited by this paper
• Receptor-mediated carcinogenesis.

  1992cited by this paper
• Mechanisms of Carcinogenesis in Risk Identification

  1992cited by this paper
• Occupational Cancer Epidemiology

  1991cited by this paper
• Increased cell division as a cause of human cancer.

  1990cited by this paper
• Mechanisms of Chemical Carcinogenesis: Theoretical and Experimental Bases

  1990cited by this paper
• Chemical Carcinogenesis in Experimental Animals and Humans

  1989cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Prevalence of ras gene mutations in human colorectal cancers

  1987cited by this paper
• Oncogenes — Implications for Human Cancer: A Review

  1984cited by this paper
• Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations

  1983cited by this paper
• Carcinogen testing: current problems and new approaches.

  1981cited by this paper
• Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

  1981cited by this paper
• Prediction of carcinogenicity based on structure, chemical reactivity and possible metabolic pathways.

  1980cited by this paper
• Mechanisms of tumor promotion and cocarcinogenesis

  1978cited by this paper
• Chemical carcinogens

  1977cited by this paper
• Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.

  1975cited by this paper
• Carcinogenesis--cellular evolution as a unifying thread: Presidential address.

  1973cited by this paper
• Toxic liver injury and carcinogenesis. Methylation of rat-liver nucleic acids by dimethylnitrosamine in vivo.

  1962cited by this paper
• Chemical Carcinogenesis

  1957cited by this paper
• A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin

  1947cited by this paper

• The role and significance of the oncobiota in selected cancers: a review

  2025cites this paper
• Healthcare Waste Toxicity: From Human Exposure to Toxic Mechanisms and Management Strategies

  2025cites this paper
• Latency, microenvironment, and the priming of a precancerous senescent cell for malignant transformation

  2025cites this paper
• A new mechanism of cancer initiation that involves the transformation of hepatocytes into preneoplastic single hepatocytes and minifoci positive for glutathione S‐transferase P‐form (GST‐P) in rat livers: 3D analysis using a vibratome

  2024cites this paper
• Modulation of host immunity by sensory neurons.

  2024cites this paper
• Large-Scale Machine Learning Analysis Reveals DNA Methylation and Gene Expression Response Signatures for Gemcitabine-Treated Pancreatic Cancer

  2023cites this paper
• Cancer-on-chip: a 3D model for the study of the tumor microenvironment

  2023cites this paper
• Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures

  2022cites this paper
• The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them

  2020cites this paper
• Artificial Food Additives and Their Impacts on Carcinogenicity

  year unknowncites this paper